Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer. - Wikidata - awgldk - TriplyDB

Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer.

Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer.

http://www.wikidata.org/entity/Q36955125

about

A pure invasive cribriform carcinoma of the breast with bone metastasis if untreated for thirteen years: a case report and literature review Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis URINARY MELATONIN IN RELATION TO POSTMENOPAUSAL BREAST CANCER RISK ACCORDING TO MELATONIN 1 RECEPTOR STATUS Identification of breast cancer patients with a high risk of developing brain metastases: a single-institutional retrospective analysis.Protein expression profile and prevalence pattern of the molecular classes of breast cancer--a Saudi population based study Magnetic resonance imaging features of breast cancer according to intrinsic subtypes: correlations with neoadjuvant chemotherapy effects.Hypothesized role of pregnancy hormones on HER2+ breast tumor development.Breast Cancer Survival Defined by the ER/PR/HER2 Subtypes and a Surrogate Classification according to Tumor Grade and Immunohistochemical Biomarkers.Gene expression in histologically normal epithelium from breast cancer patients and from cancer-free prophylactic mastectomy patients shares a similar profile.Thyroid transcription factor-1 positive primary breast cancer: a case report with review of the literature.Dietary fat intake in relation to lethal breast cancer in two large prospective cohort studies.Adult body size and physical activity in relation to risk of breast cancer according to tumor androgen receptor status How many etiological subtypes of breast cancer: two, three, four, or more?Androgen receptor expression and breast cancer survival in postmenopausal women.HSF1 drives a transcriptional program distinct from heat shock to support highly malignant human cancers.Regression of ductal carcinoma in situ after treatment with acupuncture Molecular phenotypes of unifocal, multifocal, and diffuse invasive breast carcinomas Defining breast cancer prognosis based on molecular phenotypes: results from a large cohort study.Molecular subtyping of DCIS: heterogeneity of breast cancer reflected in pre-invasive disease.Identification of early molecular markers for breast cancer.Ductal carcinoma in situ of the breast: correlation between histopathological features and age of patients Estrogen receptor-beta expression in invasive breast cancer in relation to molecular phenotype: results from the Nurses' Health Study.Biological Markers in DCIS and Risk of Breast Recurrence: A Systematic Review.Reproductive factors and risk of hormone receptor positive and negative breast cancer: a cohort study Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses' Health Study.Very low prevalence of epidermal growth factor receptor (EGFR) protein expression and gene amplification in Saudi breast cancer patients.Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to tumor characteristics.The significance of HER-2/neu receptor positivity and immunophenotype in ductal carcinoma in situ with early invasive disease.High levels of nuclear heat-shock factor 1 (HSF1) are associated with poor prognosis in breast cancer.Dense and nondense mammographic area and risk of breast cancer by age and tumor characteristics.Traditional breast cancer risk factors in relation to molecular subtypes of breast cancer Epidermal growth factor receptor in breast carcinoma: association between gene copy number and mutations.A Comparative Analysis of Biomarker Expression and Molecular Subtypes of Pure Ductal Carcinoma In Situ and Invasive Breast Carcinoma by Image Analysis: Relationship of the Subtypes with Histologic Grade, Ki67, p53 Overexpression, and DNA Ploidy Large palpable ductal carcinoma in situ is Her-2 positive with high nuclear grade COX-2 expression predicts worse breast cancer prognosis and does not modify the association with aspirin Molecular Phenotype of Breast Cancer According to Time Since Last Pregnancy in a Large Cohort of Young Women.Age of 40 years or younger is an independent risk factor for locoregional failure in early breast cancer: a single-institutional analysis in saudi arabia.Mechanobiology of tumor invasion: engineering meets oncology.HER-2 pulsed dendritic cell vaccine can eliminate HER-2 expression and impact ductal carcinoma in situ.Cell polarity, epithelial-mesenchymal transition, and cell-fate decision gene expression in ductal carcinoma in situ.

P2860

Q26865686-139DFB1F-7681-407F-937A-56D2BED1CE55 Q28280822-FBDA7BEA-F2A6-4BF4-A21C-DC97AA692D3D Q29248164-A8C49B2A-6B56-4D76-88F4-A3714C7BF1BD Q33553971-2F712F88-3588-4A6C-B8BB-C82D189BA46C Q33584351-0A09C720-53E6-46D8-BDA5-C2D18B0AF065 Q33690733-E65FE23A-5E74-47C1-BA1D-FF6BC49B0DF4 Q33745434-2BDF36C2-EC5A-4B99-9314-D250788425F9 Q33757796-DBB80997-31D9-4358-80C2-D2CC15C48C37 Q33794872-9A52A6AB-6A70-47EA-9620-9574D50F483E Q33958638-DD7FD78A-0D8F-4748-9B8A-F4928348A2B0 Q34014487-6335B805-17B9-4516-B7A1-E111DA6BF5BB Q34043711-26CE4B12-31ED-4388-9046-A73D67D387F9 Q34106175-F36DDBE3-CC0F-4DB5-82A3-6ED2DE364B63 Q34164902-8531AB87-24E5-4BE1-905D-BCDC5446259F Q34292197-196D3884-9287-44E2-A45B-4486D6D394BF Q34335729-20DC3D58-D38A-4B9B-83BA-B9B56E5F63BC Q34373120-6AFDE794-D6D6-4827-8F46-809B5168C43C Q34516677-E8670B23-39B8-4904-86F1-66C77FC98597 Q34577467-DC6C455E-2FD5-4C89-B99E-FA4DA1D09EEA Q34608080-7426835A-8A93-4BDC-8CE1-005A42078822 Q34659455-6002D46A-8CDF-4610-865C-8FAA13372A02 Q34663257-E0FB7503-574A-446A-BD61-0508761EDBAA Q34940834-4FE1B6FE-53A8-4F18-A2D0-C2152DA6FA5B Q35062955-4D3148E1-615B-4D61-93C0-150DBE5B7AD4 Q35083868-CCA8D9B1-4ABC-44CF-80C2-CC0ADE06044D Q35122066-FD9BCABC-701E-4BAC-AFD8-F5F416DB3916 Q35143969-84F45080-E02F-442E-AB48-7FEF77CD5113 Q35201328-50A6A871-6685-44DB-B63A-3E3AA60A9B86 Q35546764-303014E3-426A-4F50-91E3-493B40318D8E Q35562818-3BC26E0C-D6D8-4636-8743-8C0E4D0CFF4E Q35613614-1FD0DB66-05B3-43E1-8767-08A9951057C8 Q35642677-B84CA662-79EF-410A-BA30-7ACABEF87AAF Q35684433-D25A9F8A-AB3A-4670-8B87-2B24ED9AFA48 Q35741089-21680296-092E-46D9-892D-5425D1E485AE Q35797114-5A860C99-BCCA-4913-B287-6092B7E972D3 Q35820514-6FD77E7E-1963-4474-95CD-15C0003A3920 Q35876120-7B233395-CFE6-42FE-BA67-23C8A1BAE040 Q35877893-797E742D-EC4D-4822-9DBD-2F084F8B4371 Q35899068-13FF7C0C-E72E-4407-B531-107738DF6D58 Q35909091-194D919C-BB69-45BE-BDB7-6CCC3F00B8D6

P2860

Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer.

http://www.wikidata.org/entity/Q36955125

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Comparison of molecular phenot ...... tu and invasive breast cancer.

@en

type

label

Comparison of molecular phenot ...... tu and invasive breast cancer.

@en

prefLabel

Comparison of molecular phenot ...... tu and invasive breast cancer.

@en

P1433

Q36955125-40439178-2A2A-4752-B3C6-D366E067B201

P1476

Q36955125-98A61315-4277-4274-9780-0BA210E783A6

P2093

Q36955125-60EEC262-EE3C-41B4-A50F-C3879C2E459F

Q36955125-9CCD3E7F-A61F-43F1-BBB4-F10106BCA63E

Q36955125-A2AE3711-8C88-4313-96B6-22EE952A646F

Q36955125-AF2141B5-73AD-4FA9-B61A-CD32FA13BF12

Q36955125-B910A80F-FAF6-4796-B24A-2A12258D6F34

Q36955125-B9C6F1FA-334C-4988-A6BF-51633A4D5556

Q36955125-E150ACC2-20E4-45D6-BB2B-53260DD11B15

Q36955125-E84A7941-59A1-4A86-BF59-B9211D7B6B19

Q36955125-EC19E2AD-8FB8-4529-94A9-050F16481F24

Q36955125-F2E95691-880E-4A2A-A284-9B4C7D1578EC

P2860

Q36955125-07EF8F50-C6E0-41FD-83A2-D9BB27467E5D

Q36955125-2A291929-36B7-425E-B0CE-01D9B4A1E043

Q36955125-39B6C442-9A1B-436D-B934-1871EFCD385D

Q36955125-444DC227-BCA6-4ACD-A702-E4DA4BEA09CF

Q36955125-463929E8-97D9-4F47-9EB8-AD977453D0E5

Q36955125-46400580-F34D-4B3B-8839-F9A9E2D42CCA

Q36955125-4C082C4E-A2BB-48B7-9083-E65B03337AB3

Q36955125-5851F221-FC01-46D2-8BCB-579A21AC4D73

Q36955125-590916D2-87AB-4741-8A01-6167AF23629F

Q36955125-62FE35C3-22BC-4413-8E2D-82F4CB44DFBA

P2888

Q36955125-51F383CF-1482-4ABF-AA61-9D30B33BE022

P304

Q36955125-4B4F4E18-47E5-4C18-896C-525AD9D123A1

P31

Q36955125-0EDB02F7-0DC7-46DB-B59C-72034A1378D7

P356

Q36955125-F8B84A3E-4E66-466F-AF0F-E64944CEA253

P433

Q36955125-D0B12476-FC8A-4EAA-833A-AFD626046ADB

P478

Q36955125-20851122-8BEC-4E68-92A3-48CAAF916D71

P50

Q36955125-ACD4EB77-8D5B-419A-8523-38B49D452945

P577

Q36955125-B8FC263B-5726-4188-A8CB-19AED6FCB731

P5875

Q36955125-AEBC847A-E232-4705-9D17-B5FFC88B332A

P6179

Q36955125-7C289038-61F8-4F15-AF19-C626EE4A3157

P698

Q36955125-E677819A-ABE6-46C4-83AA-DF0892B0C51C

P932

Q36955125-40FC34C8-959F-4217-8D65-54F8EFA390B8

P356

P1433

Breast Cancer Research

P1476

Comparison of molecular phenot ...... tu and invasive breast cancer.

@en

P2093

Anne C Deitz

http://www.w3.org/2001/XMLSchema#string

Heather J Baer

http://www.w3.org/2001/XMLSchema#string

James L Connolly

http://www.w3.org/2001/XMLSchema#string

Jonathan Marotti

http://www.w3.org/2001/XMLSchema#string

Laura C Collins

http://www.w3.org/2001/XMLSchema#string

Laurie Galaburda

http://www.w3.org/2001/XMLSchema#string

Mark Galan

http://www.w3.org/2001/XMLSchema#string

Rulla M Tamimi

http://www.w3.org/2001/XMLSchema#string

Stuart J Schnitt

http://www.w3.org/2001/XMLSchema#string

Yineng Fu

http://www.w3.org/2001/XMLSchema#string

P2860

Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Repeated observation of breast tumor subtypes in independent gene expression data sets

Breast carcinoma in situ: risk factors and screening patterns

Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype

Distinctive gene expression patterns in human mammary epithelial cells and breast cancers.

Epidemiology of basal-like breast cancer.

Pathological and biological differences between screen-detected and interval ductal carcinoma in situ of the breast

Molecular classification and molecular forecasting of breast cancer: ready for clinical application?

Abrogated response to cellular stress identifies DCIS associated with subsequent tumor events and defines basal-like breast tumors

P2888

P304

R67

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/BCR2128

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-08-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23150998

http://www.w3.org/2001/XMLSchema#string

P6179

1001913224

http://www.w3.org/2001/XMLSchema#string

P698

18681955

http://www.w3.org/2001/XMLSchema#string

P932

2575540

http://www.w3.org/2001/XMLSchema#string